Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice

Diabetes Res Clin Pract. 2007 Sep;77(3):492-3. doi: 10.1016/j.diabres.2007.01.008. Epub 2007 Feb 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aged
  • Antihypertensive Agents / therapeutic use
  • Benzimidazoles / therapeutic use*
  • Biphenyl Compounds
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Drug Evaluation
  • Female
  • Humans
  • Hypertension / drug therapy
  • Hypertrophy, Left Ventricular / drug therapy*
  • Male
  • Middle Aged
  • Tetrazoles / therapeutic use*

Substances

  • Antihypertensive Agents
  • Benzimidazoles
  • Biphenyl Compounds
  • Tetrazoles
  • candesartan